Steven D. Ertel, EVP & Chief Operating Officer at ACCELERON PHARMA INC (XLRN), sold 32,270 shares at $32.00 ($1.0M) on 2016-04-07, disclosed to the SEC on 2016-04-08.
Open-market sale of $1.0M XLRN by EVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |
| XLRN | SELL | 2015-07-17 | $63K | — | Filing → |